Effect of TGF-β1 on the Migration and Recruitment of Mesenchymal Stem Cells After Vascular Balloon Injury: Involvement of Matrix Metalloproteinase-14

Overview

Journal Sci Rep

Specialty Science

Date 2016 Feb 17

PMID 26880204

Citations 20

Authors

Wei Zhao

Chengyan Wang

Ruixue Liu

Cuilei Wei

Juncang Duan

Kejian Liu

Shugang Li

Hong Zou

Jin Zhao

Lianghai Wang

Yan Qi

Weihua Liang

Jinfang Jiang

Wenjie Zhang

Lijuan Pang

Feng Li

Affiliations

Soon will be listed here.

Abstract

Restenosis or occlusion after vascular procedures is ascribed to intimal hyperplasia. Transforming growth factor (TGF)-β1 is involved in recruitment of mesenchymal stem cells (MSCs) following arterial injury, and its release from latent TGF-binding protein by matrix metalloproteinase (MMP)-14-induced proteolysis contributes to neointima formation. However, the relationship between MMP-14 and TGF-β1 activation in restenosis is unknown. This study investigated the relationship using a rat model of balloon-induced injury. Rats were assigned to vehicle-, SB431542 (SB)-, or recombinant human (rh)TGF-β1-treated groups and examined at various time points after balloon-induced injury for expression of TGF-β1/Smad signalling pathway components, MMP-14 and MSCs markers including Nestin, CD29, and Sca1(+)CD29(+)CD11b/c(-)CD45(-). Intimal hyperplasia was reduced in SB- and rhTGF-β1-treated rats. The expression of TGF-β1, TGF-β1RI, and Smad2/3 was decreased, but the levels of phosphorylated Smad2/3 were higher in SB-treated rats than vehicle-treated after 7 days to 14 days. rhTGF-β1 administration decreased the expression of TGF-β1/Smad pathway proteins, except for TGF-β1RI. Nestin and CD29 expression and the number of Sca1(+)CD29(+)CD11b(-)CD45(-) cells were reduced, whereas MMP-14 expression was increased after SB431542 and rhTGF-β1 administration. These results suggest that TGF-β1/Smad signalling and MMP-14 act to recruit MSCs which differentiate to vascular smooth muscle cells and mesenchymal-like cells that participate in arterial repair/remodelling.

Citing Articles

Extracellular vesicles derived from SARS-CoV-2 M-protein-induced triple negative breast cancer cells promoted the ability of tissue stem cells supporting cancer progression.

Nguyen H, Vuong C, Fukushige M, Usuda M, Takagi L, Yamashita T Front Oncol. 2024; 14:1346312.

PMID: 38515582 PMC: 10955079. DOI: 10.3389/fonc.2024.1346312.

Impact of the transforming growth factor-β pathway on vascular restenosis and its mechanism.

Luo Z, Li X, Wang L, Shu C Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023; 48(8):1252-1259.

PMID: 37875366 PMC: 10930841. DOI: 10.11817/j.issn.1672-7347.2023.230064.

Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases.

Yu S, Yu S, Liu H, Liao N, Liu X Stem Cell Res Ther. 2023; 14(1):235.

PMID: 37667383 PMC: 10478247. DOI: 10.1186/s13287-023-03476-4.

Pathogenesis of pulmonary hypertension caused by left heart disease.

Xiao M, Lai D, Yu Y, Wu Q, Zhang C Front Cardiovasc Med. 2023; 10:1079142.

PMID: 36937903 PMC: 10020203. DOI: 10.3389/fcvm.2023.1079142.

Macrophage TGF-β signaling is critical for wound healing with heterotopic ossification after trauma.

Patel N, Nunez J, Sorkin M, Marini S, Pagani C, Strong A JCI Insight. 2022; 7(20).

PMID: 36099022 PMC: 9714796. DOI: 10.1172/jci.insight.144925.

References

Merzkirch C, Davies N, Zilla P . Engineering of vascular ingrowth matrices: are protein domains an alternative to peptides?. Anat Rec. 2001; 263(4):379-87. DOI: 10.1002/ar.1118. View

Kolf C, Cho E, Tuan R . Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther. 2007; 9(1):204. PMC: 1860068. DOI: 10.1186/ar2116. View

Sato M, Ohsaki Y, Tobise K . Transforming growth factor-beta 1 proliferated vascular smooth muscle cells from spontaneously hypertensive rats. Am J Hypertens. 1995; 8(2):160-6. DOI: 10.1016/0895-7061(94)00191-D. View

Ryan S, Koteliansky V, Gotwals P, Lindner V . Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury. J Vasc Res. 2003; 40(1):37-46. DOI: 10.1159/000068937. View

Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T . Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002; 8(4):403-9. DOI: 10.1038/nm0402-403. View

Hao H, Gabbiani G, Bochaton-Piallat M . Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol. 2003; 23(9):1510-20. DOI: 10.1161/01.ATV.0000090130.85752.ED. View

Dzau V, Braun-Dullaeus R, Sedding D . Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med. 2002; 8(11):1249-56. DOI: 10.1038/nm1102-1249. View

Shoji M, Koba S, Kobayashi Y . Roles of bone-marrow-derived cells and inflammatory cytokines in neointimal hyperplasia after vascular injury. Biomed Res Int. 2014; 2014:945127. PMC: 3914557. DOI: 10.1155/2014/945127. View

Welt F, Rogers C . Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol. 2002; 22(11):1769-76. DOI: 10.1161/01.atv.0000037100.44766.5b. View

10.

Rodriguez-Vita J, Sanchez-Lopez E, Esteban V, Ruperez M, Egido J, Ruiz-Ortega M . Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation. 2005; 111(19):2509-17. DOI: 10.1161/01.CIR.0000165133.84978.E2. View

11.

Tulis D . Rat carotid artery balloon injury model. Methods Mol Med. 2008; 139:1-30. PMC: 2819386. DOI: 10.1007/978-1-59745-571-8_1. View

12.

Chen Q, Jin M, Yang F, Zhu J, Xiao Q, Zhang L . Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm. 2013; 2013:928315. PMC: 3694547. DOI: 10.1155/2013/928315. View

13.

Casteilla L, Planat-Benard V, Laharrague P, Cousin B . Adipose-derived stromal cells: Their identity and uses in clinical trials, an update. World J Stem Cells. 2011; 3(4):25-33. PMC: 3097937. DOI: 10.4252/wjsc.v3.i4.25. View

14.

Reneker L, Bloch A, Xie L, Overbeek P, Ash J . Induction of corneal myofibroblasts by lens-derived transforming growth factor beta1 (TGFbeta1): a transgenic mouse model. Brain Res Bull. 2009; 81(2-3):287-96. PMC: 2814984. DOI: 10.1016/j.brainresbull.2009.10.019. View

15.

Bauters C, Isner J . The biology of restenosis. Prog Cardiovasc Dis. 1997; 40(2):107-16. DOI: 10.1016/s0033-0620(97)80003-5. View

16.

Wang C, Cherng W, Yang N, Kuo L, Hsu C, Yeh H . Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler Thromb Vasc Biol. 2007; 28(1):54-60. DOI: 10.1161/ATVBAHA.107.147256. View

17.

Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P . MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood. 2007; 109(9):4055-63. DOI: 10.1182/blood-2006-10-051060. View

18.

Driver J, Weber C, Callaci J, Kothari A, Zapf M, Roper P . Alcohol inhibits osteopontin-dependent transforming growth factor-β1 expression in human mesenchymal stem cells. J Biol Chem. 2015; 290(16):9959-73. PMC: 4400371. DOI: 10.1074/jbc.M114.616888. View

19.

Hoglund V, Dong X, Majesky M . Neointima formation: a local affair. Arterioscler Thromb Vasc Biol. 2010; 30(10):1877-9. PMC: 3049730. DOI: 10.1161/ATVBAHA.110.211433. View

20.

Malinowski M, Pietraszek K, Perreau C, Boguslawski M, Decot V, Stoltz J . Effect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase-14. PLoS One. 2012; 7(12):e50709. PMC: 3517548. DOI: 10.1371/journal.pone.0050709. View